ArticleOpen life sciences2024

TAK-242 alleviates diabetic cardiomyopathy via inhibiting pyroptosis and TLR4/CaMKII/NLRP3 pathway.

Xiaolong Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.